Resumen
Due to advances in chemotherapy and radiotherapy over recent decades, Hodgkin lymphoma is now a curable disease in the vast majority of younger patients. While treatment has become very effective, patients are burdened with significant short- and long-term side effects such as infections, infertility, organ failure and secondary malignancies. In this article we review the strategies that have been used to reduce the toxicity of treatment while maintaining high cure rates, and how the current treatment of Hodgkin lymphoma has evolved based on the success of these strategies.